摘要
目的:探讨国内政策法规变动对仿制药开发和申报的影响。方法:通过整理近期出台的政策法规,分析其中与仿制药开发相关的政策变化,给予相应的开发建议。结果与结论:针对当前政策变化对仿制药开发带来的可能影响,提出一些建议,希望能给国内其他仿制药研发机构予以参考。
Objective: To explore the impact of recent changes in domestic policies and regulations on the development and appli- cation of generic drugs. Methods: Through the collation of the recent regulatory documents, the policy changes for generic drugs were analyzed, and the corresponding development proposals were provided. Results and Conclusion: According to the possible impact of current policy changes on generic drug development, the relative solutions are proposed with the aim to provide certain reference for ge- neric pharmaceutical R & D institutions.
作者
沈威
金燕芬
Shen Wei Jin Yanfen(Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd. , Hangzhou 310011, China Hangzhou Huadong Medicine Group Pharmaceutical Research Institute Co. Ltd.)
出处
《中国药师》
CAS
2017年第2期321-324,共4页
China Pharmacist
关键词
仿制药
政策法规
备案
一致性评价
Generic drugs
Policies and regulations
Record
Consistency evaluation